Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Josamycin propionate is a propionate ester of the macrolide antibiotic josamycin. It is a small molecule antibiotic used to treat various bacterial infections, including those of the respiratory tract, skin, and soft tissues. Like other macrolides, it exerts its antibacterial effect by binding to the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis. It is particularly effective against Gram-positive bacteria and some Gram-negative organisms. In China, it is marketed by companies such as Chongqing Southwest Pharmaceutical in formulations like granules for oral administration, often used in pediatric populations due to its improved palatability compared to the base form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on josamycin propionate.